How melanoma can resist newly approved drug combo therapy

Researchers have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *